SEC Form 4 · accession 0000200406-26-000179
JOHNSON & JOHNSON · JNJ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Timothy Schmid
Officer — EVP, WW Chair, MedTech
Period of report
Sep 2, 2026
Accepted (ET)
Sep 4, 2026 · 9:08 am EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000200406
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 2, 2026 | M | 11,070 | $131.94 | A | 36,517 | D | |
| Common Stock | Sep 2, 2026 | S | 11,070 | $274.74 | D | 25,447 | D | |
| Common Stock | Sep 2, 2026 | M | 22,527 | $151.41 | A | 47,974 | D | |
| Common Stock | Sep 2, 2026 | S | 22,527 | $274.74 | D | 25,447 | D | |
| Common StockF1 | holding | — | — | — | 758 | I | By 401k | |
| Common StockF2 | holding | — | — | — | 46 | I | By ESOP |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Options (Right to Buy)F3 | $131.94 | Sep 2, 2026 | M | 11,070 | D | Feb 11, 2022 | Feb 11, 2029 | Common Stock | 11,070 | 0 | D |
| Employee Stock Options (Right to Buy)F3 | $151.41 | Sep 2, 2026 | M | 22,527 | D | Feb 10, 2023 | Feb 10, 2030 | Common Stock | 22,527 | 0 | D |
Explanation of responses
- F1Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (8/31/2026).
- F2Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (8/31/2026).
- F3Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable on the third anniversary of the grant date.